JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan

  • 0Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, 7 Chung-Shan South Rd., Taipei, 10051, Taiwan. cyw1965@gmail.com.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders +

|

April 20, 2024

|

April 20, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Digital health technology improved glycemic control in type 2 diabetes patients using insulin glargine 300 U/mL with the Mallya cap and Health2Sync platform. This connected ecosystem supports better diabetes management.

Area Of Science

  • Endocrinology
  • Digital Health
  • Diabetes Management

Background

  • Health2Sync (H2S) is a digital platform for diabetes coaching.
  • The Mallya cap transforms insulin pens into smart devices, syncing data to H2S.
  • This study assessed insulin glargine 300 U/mL (Gla-300) with H2S and Mallya cap in type 2 diabetes (T2D) patients in Taiwan.

Purpose Of The Study

  • Evaluate the effectiveness of the Gla-300 + Cap + App program on clinical outcomes.
  • Assess changes in glycated hemoglobin (HbA1c) and goal attainment.
  • Investigate hypoglycemia incidence and device usage metrics.

Main Methods

  • Retrospective cohort study of 83 T2D patients using H2S and Mallya cap.
  • Included adults aged ≥20 years initiating Gla-300 with the connected system.
  • Collected 90-day follow-up data from H2S for HbA1c, hypoglycemia, and usage.

Main Results

  • HbA1c significantly reduced in both new (-2.4%) and previous (-0.5%) Gla-300 users (p<0.05).
  • 43.4% of users achieved >0.5% HbA1c reduction at follow-up.
  • Greater HbA1c reduction correlated with higher baseline HbA1c and longer Mallya cap use.

Conclusions

  • The Gla-300 + Cap + App program, a connected digital health ecosystem, improves glycemic control in T2D.
  • Digital technology integration aids in managing diabetes and achieving better health outcomes.
  • This approach offers a promising strategy for enhancing diabetes care.

Keywords:

Related Concept Videos

Diabetes: Management and Pharmacotherapy 01:15

275

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications 01:15

528

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Diabetes Mellitus: Type 2 and Gestational 01:22

2.3K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Carbohydrate Metabolism 01:36

11.1K

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

Glucagon-like Receptor Agonists 01:24

319

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Oral Hypoglycemic Agents: Biguanides and Glitazones 01:26

195

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...